Willis Towers Watson delivered strong second quarter 2025 results with revenue of $2.26 billion, flat year-over-year due to the TRANZACT sale, but with 5% organic revenue growth. Diluted EPS increased by 144% to $3.32, and adjusted diluted EPS rose by 20% to $2.86. Operating margin expanded to 16.3%, and adjusted operating margin reached 18.5%, reflecting significant improvements in profitability.
Revenue for Q2 2025 was $2.26 billion, flat compared to the prior-year quarter, primarily due to the sale of TRANZACT.
Organic Revenue growth was strong at 5% for the quarter, indicating underlying business health.
Diluted Earnings per Share significantly increased by 144% to $3.32, while Adjusted Diluted Earnings per Share grew by 20% to $2.86.
Operating Margin improved to 16.3%, and Adjusted Operating Margin expanded to 18.5%, reflecting enhanced profitability.
WTW expects to achieve mid-single digit organic revenue growth, operating margin expansion, adjusted earnings per share growth, and free cash flow margin expansion for the full year 2025. The company anticipates approximately $1.5 billion in share repurchases, subject to market conditions.